Tri Locum Partners LP Has $3.59 Million Position in Stevanato Group S.p.A. $STVN

Key Points

• Tri Locum Partners LP reduced its stake in Stevanato Group S.p.A. by 84.3% to 175,681 shares, now representing about 1.8% of their portfolio.
• Multiple institutional investors have also adjusted their positions in Stevanato Group, with Wells Fargo & Company increasing its stake by 680.3% in the fourth quarter.
• Stevanato Group has received a consensus rating of "Moderate Buy" from analysts, with one Strong Buy, three Buy, and two Hold ratings reported.

Tri Locum Partners LP reduced its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 84.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 175,681 shares of the company's stock after selling 946,123 shares during the period. Stevanato Group accounts for approximately 1.8% of Tri Locum Partners LP's investment portfolio, making the stock its 19th biggest position. Tri Locum Partners LP owned approximately 0.06% of Stevanato Group worth $3,587,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Conestoga Capital Advisors LLC increased its holdings in shares of Stevanato Group by 1.3% in the first quarter. Conestoga Capital Advisors LLC now owns 8,189,926 shares of the company's stock valued at $167,238,000 after purchasing an additional 106,930 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Stevanato Group by 13.3% in the first quarter. T. Rowe Price Investment Management Inc. now owns 3,744,714 shares of the company's stock valued at $76,468,000 after purchasing an additional 439,722 shares during the last quarter. TimesSquare Capital Management LLC increased its holdings in shares of Stevanato Group by 2.1% in the first quarter. TimesSquare Capital Management LLC now owns 3,358,966 shares of the company's stock valued at $68,590,000 after purchasing an additional 70,437 shares during the last quarter. Bamco Inc. NY increased its holdings in shares of Stevanato Group by 7.9% in the fourth quarter. Bamco Inc. NY now owns 1,818,181 shares of the company's stock valued at $39,618,000 after purchasing an additional 133,000 shares during the last quarter. Finally, Jennison Associates LLC increased its holdings in shares of Stevanato Group by 27.9% in the first quarter. Jennison Associates LLC now owns 1,188,057 shares of the company's stock valued at $24,260,000 after purchasing an additional 259,231 shares during the last quarter.

Analyst Upgrades and Downgrades

Separately, William Blair reiterated an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy".

Stevanato Group Stock Performance

Shares of Stevanato Group stock traded down €0.32 during trading on Friday, reaching €23.14. The company's stock had a trading volume of 254,200 shares, compared to its average volume of 356,268. The business's 50-day moving average price is €24.22 and its 200-day moving average price is €22.51. The firm has a market cap of $7.01 billion, a PE ratio of 42.85, a P/E/G ratio of 2.17 and a beta of 0.55. Stevanato Group S.p.A. has a 52 week low of €17.12 and a 52 week high of €28.00. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.